US 10093900
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted A61KA61K2039/505A61K2039/804
Quick answer
US patent 10093900 (Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene) held by Precision BioSciences, Inc. expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Precision BioSciences, Inc.
- Grant date
- Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/804, A61K2239/31, A61K2239/38